查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1634163

全球眼科缝合线市场 - 2025 - 2033

Global Ophthalmic Sutures Market - 2025 - 2033
出版日期: | 出版商: DataM Intelligence | 英文 159 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球眼科缝合线市场达到4.637亿美元，预计2033年将达到8.715亿美元，2025-2033年预测期间复合年增长率为7.3%。

眼科缝合线是专门的医用线或线，用于闭合眼睛或周围眼组织的手术切口或伤口。这些缝线旨在提供精确的组织近似，支持癒合，并最大限度地减少对脆弱眼部结构的创伤。它们在眼科手术中至关重要，包括角膜、巩膜、虹膜、眼睑和眼眶组织的手术。眼科缝合线非常薄且精緻，以匹配眼组织敏感和复杂的性质。

在眼部疾病盛行率增加和手术技术进步等因素的推动下，眼科缝合线市场持续成长。例如，2024 年10 月，全球领先的医疗技术公司Corza Medical 致力于提供卓越的服务、值得信赖的性能和卓越的价值，推出了其创新的新系列Onatec 眼科显微手术缝合线，并在2020 年的美国眼科学会(AAO) 会议上亮相。

市场动态：

驱动程式和限制

眼部疾病盛行率上升

眼部疾病盛行率的上升极大地推动了眼科缝合线市场的成长，预计将在预测期内推动市场的成长。白内障是全世界最常见的眼部疾病之一，尤其是在老年族群。随着年龄的增长，患白内障的可能性也会增加。白内障手术是全世界最常见的手术之一。

例如，根据 WK 眼科研究所的数据，全世界每年约进行 2,800 万例白内障手术，其中近 15% 发生在美国。白内障手术数量预计将进一步增加，从而增加对眼科缝合线的需求。

糖尿病视网膜病变是一种影响视网膜的糖尿病併发症，越来越受到人们的关注。国际糖尿病联盟 (IDF) 报告称，全球约有 4.63 亿糖尿病患者，其中高达 28% 面临糖尿病视网膜病变的风险。晚期糖尿病视网膜病变的治疗通常涉及玻璃体切除术（去除眼睛中的玻璃体凝胶），这需要专门的缝合线来修復和闭合手术期间形成的切口。

老年黄斑部病变（AMD）是另一种随着年龄增长而变得越来越常见的眼部疾病。据美国眼科学会称，到 2040 年，预计将有 2.88 亿人患有 AMD。虽然 AMD 通常需要注射等药物治疗，但晚期病例可能需要手术干预，例如视网膜手术，其中眼科缝合对于组织修復和闭合至关重要。

转向无缝线手术技术

向无缝线手术技术的转变预计将阻碍眼科缝合线市场的成长。虽然眼科缝合线对于许多眼科手术至关重要，但无缝线技术的开发和采用正在减少各种外科手术中对传统缝合线的依赖。例如，在白内障手术中，采用飞秒雷射技术减少了缝合的需要。这项技术使外科医生能够进行精确的角膜切口，通常不需要缝合来闭合。

外科医生越来越多地在白内障和屈光手术中使用自封闭角膜切口。这些切口自然闭合，无需缝合，完全减少了缝合的需要。这种趋势在屈光手术（例如 LASIK、PRK）中尤其明显，其中切口小而精确，通常无需缝合，从而实现更快的恢復时间和最小化疤痕。

在许多眼科手术中，组织黏合剂或氰基丙烯酸酯胶作为缝合线的替代品越来越受欢迎，特别是在角膜伤口修復和视网膜手术等手术中。这些黏合剂为某些类型的眼部手术提供了更快、更有效的闭合，与传统缝线相比具有多种优势，例如易于使用、缩短手术时间和减少併发症。例如，在视网膜剥离手术中，有时会使用氰基丙烯酸酯组织黏合剂来密封视网膜撕裂，从而无需缝合。

有关此报告的更多详细资讯 - 索取样品

目录

第一章：市场介绍和范围

  • 报告的目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按类型分類的片段
  • 按吸收能力摘录
  • 按应用程式片段
  • 最终使用者的片段
  • 按地区分類的片段

第 3 章：动力学

  • 影响因素
    • 司机
      • 眼部疾病盛行率上升
    • 限制
      • 转向无缝线手术技术
    • 机会
    • 影响分析

第 4 章：策略洞察与产业展望

  • 市场领导者和先驱
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的知名领导者
    • 拥有成熟产品的市场领导者
  • 新兴新创企业和关键创新者
  • CXO 观点
  • 最新进展和突破
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态

第 5 章：眼科缝合线市场（按类型）

  • 天然缝线
  • 合成缝线

第 6 章：眼科缝合线市场（依吸收能力）

  • 可吸收缝线
  • 不可吸收缝线

第 7 章：眼科缝合线市场（按应用）

  • 白内障手术
  • 角膜移植手术
  • 玻璃体切除手术
  • 虹膜切除手术
  • 眼部整形手术
  • 其他的

第 8 章：眼科缝合线市场（依最终用户）

  • 医院
  • 眼科诊所
  • 门诊手术中心
  • 其他的

第 9 章：眼科缝合线市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的主要发展
  • 公司基准化分析

第 11 章：公司简介

  • B. Braun SE
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
    • SWOT分析
  • Johnson & Johnson Medical NV.
  • Medtronic plc
  • DemeTECH Corporation
  • Corza Medical
  • KATSAN Katgut Industry and Trade Inc.
  • Golnit
  • Accutome Inc.
  • Aurolab
  • Dolphin Sutures

第 12 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 13 章：附录

简介目录
Product Code: MD8962

The global ophthalmic sutures market reached US$ 463.7 million in 2024 and is expected to reach US$ 871.5 million by 2033, growing at a CAGR of 7.3% during the forecast period 2025-2033.

Ophthalmic sutures are specialized medical threads or strands used to close surgical incisions or wounds in the eye or surrounding ocular tissues. These sutures are designed to provide precise tissue approximation, support healing, and minimize trauma to delicate ocular structures. They are crucial in ophthalmic surgeries, including procedures on the cornea, sclera, iris, eyelids, and orbital tissues. Ophthalmic sutures are extremely thin and delicate to match the sensitive and intricate nature of eye tissues.

The ophthalmic sutures market experiencing consistent growth, driven by factors such as the increasing prevalence of eye disorders and advancements in surgical techniques. For instance, in October 2024, Corza Medical, a leading global medical technology company committed to remarkable service, trusted performance and outstanding value, launched its innovative new line of Onatec ophthalmic microsurgical sutures, unveiled at the American Academy of Ophthalmology (AAO) conference in Chicago.

Market Dynamics: Drivers & Restraints

Rising prevalence of eye disorders

The rising prevalence of eye disorders is significantly driving the growth of the ophthalmic sutures market and is expected to drive the market over the forecast period. Cataracts are one of the most common eye conditions worldwide, particularly in the aging population. As people age, the likelihood of developing cataracts increases. Cataract surgery is one of the most common procedures performed worldwide.

For instance, according to the WK Eye Institute, there are roughly 28 million cataract surgeries performed worldwide each year, with nearly 15 percent occurring in the United States. The number of cataract surgeries is projected to rise further, consequently increasing the demand for ophthalmic sutures.

Diabetic retinopathy, a complication of diabetes that affects the retina, is a growing concern. The International Diabetes Federation (IDF) reports that there are approximately 463 million people with diabetes worldwide, and up to 28% of them are at risk for diabetic retinopathy. Treatment for advanced stages of diabetic retinopathy often involves vitrectomy (removal of the vitreous gel from the eye), which requires specialized sutures to repair and close incisions made during surgery.

Age-related macular degeneration (AMD) is another eye disorder that is becoming more common with aging. By 2040, 288 million people are expected to suffer from AMD, according to the American Academy of Ophthalmology. While AMD typically requires medical treatments like injections, advanced cases may need surgical interventions, such as retinal surgeries, where ophthalmic sutures are essential for tissue repair and closure.

Shift towards sutureless surgical techniques

Shift towards sutureless surgical techniques is expected to hamper the growth of the ophthalmic sutures market. While ophthalmic sutures are essential for many eye surgeries, the development and adoption of sutureless techniques are reducing the dependency on traditional sutures in various surgical procedures. For instance, in cataract surgeries, adopting femtosecond laser technology has reduced the need for sutures. This technology enables surgeons to perform precise corneal incisions that often do not require sutures for closure.

Surgeons are increasingly utilizing self-sealing corneal incisions in cataract and refractive surgeries. These incisions naturally close without requiring sutures, reducing the need for suturing altogether. This trend is particularly evident in refractive surgeries (e.g., LASIK, PRK) where small, precise incisions are made, often without sutures, leading to faster recovery times and minimal scarring.

Tissue adhesives or cyanoacrylate-based glues are gaining popularity as alternatives to sutures in many ophthalmic surgeries, especially for procedures like corneal wound repair and retinal surgeries. These adhesives provide a quicker and more efficient closure for certain types of eye surgeries, offering several advantages over traditional sutures, such as ease of application, reduced surgical time, and fewer complications. For instance, in retinal detachment surgeries, cyanoacrylate tissue adhesives are sometimes used to seal retinal tears, eliminating the need for sutures.

For more details on this report - Request for Sample

Segment Analysis

The global ophthalmic sutures market is segmented based on type, absorption capacity, application, end-user and region.

Absorption Capacity:

The non-absorbable sutures segment is expected to dominate the ophthalmic sutures market share

Non-absorbable sutures are preferred in surgeries where long-term tissue support is crucial, such as scleral or corneal repairs, retinal surgeries, and glaucoma surgeries. These surgeries often involve tissues that take a longer time to heal or need sustained support. For instance, in glaucoma surgeries like trabeculectomy, non-absorbable sutures are used to ensure that the incision remains closed until the wound fully heals. Their ability to provide durable support is essential for reducing the risk of postoperative complications like wound dehiscence (wound opening).

Nylon and polypropylene, the two most common materials used for non-absorbable sutures, offer superior tensile strength and durability compared to absorbable sutures. This makes them ideal for use in areas that experience high mechanical stress or require precise closure. For instance, in corneal surgeries, such as penetrating keratoplasty (corneal transplants), where precise wound closure is critical to prevent infection and ensure proper healing, non-absorbable sutures ensure that the incision site is securely closed for a prolonged period.

Non-absorbable sutures do not dissolve over time, which makes them suitable for applications where the removal of sutures is not necessary. For instance, in cataract surgeries, retinal procedures, or glaucoma surgeries, non-absorbable sutures can remain in place indefinitely without causing issues, reducing the need for follow-up procedures. In cases like eyelid surgeries, the sutures may remain permanently in place, providing lasting structural support to the eyelids.

Geographical Analysis

North America is expected to hold a significant position in the ophthalmic sutures market share

Ophthalmic diseases such as cataracts, glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, and other vision-related disorders are more prevalent in North America especially in the United States and Canada, particularly due to an aging population and increasing lifestyle-related factors like diabetes. For instance, according to the American Academy of Ophthalmology (AAO), by 2050, the number of people in the U.S. with diabetic retinopathy is expected to rise to 14.6 million, driving an increased need for surgeries that require ophthalmic sutures.

The ophthalmic sutures market in North America benefits from a well-established healthcare market, with high adoption rates of ophthalmic procedures. In particular, cataract surgeries in the U.S. are expected to increase due to the country's aging population and advancements in surgical techniques.

For instance, the National Eye Institute (NEI) projects that cataract surgery in the U.S. alone will rise sharply in the coming decades, from approximately 3.6 million in 2020 to 5.7 million by 2050. Cataract surgeries often require sutures to close the incision, and as the number of surgeries increases, so does the demand for ophthalmic sutures.

Asia-Pacific is growing at the fastest pace in the ophthalmic sutures market

The Asia-Pacific region has a large and growing population that is increasingly affected by a range of eye disorders. Conditions such as cataracts, glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, and corneal diseases are becoming more prevalent due to an aging population, lifestyle changes, and rising diabetes rates. For instance, Cataracts are a major concern in Asia. The World Health Organization (WHO) estimates that by 2030, over 50 million people in the region will be living with cataracts, and it remains the leading cause of blindness.

In countries like India, China, and Japan, where the aging population is rapidly increasing, the demand for cataract surgeries and related ophthalmic treatments is soaring. Cataract surgery often involves the use of ophthalmic sutures for wound closure, driving the demand for sutures.

For instance, the World Bank's Implementation Completion Report provides information on the major achievements of the Cataract Blindness project in India. Based on an estimated 3.5 million cataract surgeries each year, about 320,000 people are saved from blindness annually. Overall population prevalence of cataract blindness declined by 26 percent, from 1.5 percent at baseline to 1.1 percent, during the program period. These rising cataract surgeries boost the demand for ophthalmic sutures in the region.

Competitive Landscape

The major global players in the ophthalmic sutures market include B. Braun SE, Johnson & Johnson Medical NV., Medtronic plc, DemeTECH Corporation, Corza Medical, KATSAN Katgut Industry and Trade Inc., Golnit, Accutome Inc. Aurolab, Dolphin Sutures and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Ophthalmic Sutures market report delivers a detailed analysis with 70 key tables, more than 64 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Absorption Capacity
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Eye Disorders
    • 3.1.2. Restraints
      • 3.1.2.1. Shift Towards Sutureless Surgical Techniques
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. SWOT Analysis
  • 4.9. Unmet Needs and Gaps
  • 4.10. Recommended Strategies for Market Entry and Expansion
  • 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.12. Pricing Analysis and Price Dynamics

5. Ophthalmic Sutures Market, By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Natural Sutures*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Synthetic Sutures

6. Ophthalmic Sutures Market, By Absorption Capacity

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 6.1.2. Market Attractiveness Index, By Absorption Capacity
  • 6.2. Absorbable Sutures*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Non-Absorbable Sutures

7. Ophthalmic Sutures Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Cataract Surgery*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Corneal Transplantation Surgery
  • 7.4. Vitrectomy Surgery
  • 7.5. Iridectomy Surgery
  • 7.6. Oculoplastic Surgery
  • 7.7. Others

8. Ophthalmic Sutures Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ophthalmic Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Others

9. Ophthalmic Sutures Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. B. Braun SE*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Johnson & Johnson Medical NV.
  • 11.3. Medtronic plc
  • 11.4. DemeTECH Corporation
  • 11.5. Corza Medical
  • 11.6. KATSAN Katgut Industry and Trade Inc.
  • 11.7. Golnit
  • 11.8. Accutome Inc.
  • 11.9. Aurolab
  • 11.10. Dolphin Sutures

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us